Vancity Investment Management LTD Gilead Sciences, Inc. Transaction History

Vancity Investment Management LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 07, 2021	SELL	$67.69 - $73.03 $9.24 Million - $9.97 Million	-136,452 Closed	0 $0
Q2 2021 Jul 20, 2021	BUY	$63.47 - $69.35 $775,349 - $847,179	12,216 Added 9.83%	136,452 $9.4 Million
Q1 2021 Apr 28, 2021	BUY	$60.0 - $68.46 $141,480 - $161,428	2,358 Added 1.93%	124,236 $8.03 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $6.9 Million - $7.87 Million	121,878 New	121,878 $7.1 Million

1,879

1.02B

12M

8.96M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Vancity Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Vancity Investment Management LTD with notifications on news.